Anavex Life Sciences Corp (AVXL)

[RedShoulder]

AVXL stands alone. SAVA failed. The brain bleeding amyloid stocks and now SAVA will not be competitive.

SAVA:

"ADAS-Cog11 scores changed from 19.1 (±9.2) to 19.6 (±13.3)"

"In the moderate sub-group, ADAS-Cog scores worsened, from 25.7 (±9.2) to 30.1 (±13.1)"

The data speaks for itself. Not a meaningful improvement.

SAVA SP is tanking: 27.77 down -8.67 loss (-23.79%)

I would expect that some AD investors will be moving funds out of the amyloid stocks and now also SAVA into AVXL in the future.